SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: JOHN W. who wrote (2759)11/13/1997 5:47:00 PM
From: Henry Niman   of 6136
 
John, As I said a month or two ago, Dr. Ho is overly optimistic:
BUSINESS WEEK ONLINE
November 13, 1997

Edited by Douglas Harbrecht

THE AIDS DRUG COCKTAIL IS STILL
NO CURE

In a highly publicized development last year, a few AIDS researchers
began to suggest that a cure could be in sight for the scourge of AIDS.
Dr. David Ho of the Aaron Diamond AIDS Research Center and
others based this hope on encouraging results from a potent
combination of three drugs. The drugs were able to reduce the amount
of virus in the blood to undetectable levels in many patients. Ho and
colleagues suggested that using these drugs to keep HIV in check in
the blood could enable the body to clear itself of all traces of the virus
within three years. However, two new studies published in the Nov. 14
issue of the journal Science show that hopes of a cure are vastly
premature. The separate studies reveal that despite up to 30 months of
treatment with the potent drug cocktail, the virus still lurks hidden in the
immune-system cells of patients. That helps explain why patients who
skip doses or stop taking their drugs see blood levels of the virus soar
again. And it means that victims will probably have to keep taking the
expensive drug combination (assuming that the drugs continue to work
and their often-serious side effects can be kept in check) for the rest of
their lives. "The bad news is that we can't yet get rid of the virus
entirely," says Dr. Robert F. Siliciano of Johns Hopkins, the leader of
one of the studies. That's why many scientific groups are now stepping
up efforts to find other ways of attacking the virus, such as
manipulating biochemical pathways -- involving molecules called
chemokines -- that are crucial to viral entry into cells.

By John Carey in Washington
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext